These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [In vitro susceptibility of respiratory isolates of Streptococcus pneumoniae and Streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of e-BASKETT-II surveillance study]. Gür D, Mülazimoğlu L, Unal S, e-BASKETT-II Calişma Grubu. Mikrobiyol Bul; 2007 Jan; 41(1):1-9. PubMed ID: 17427547 [Abstract] [Full Text] [Related]
8. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Pérez-Trallero E, Fernández-Mazarrasa C, García-Rey C, Bouza E, Aguilar L, García-de-Lomas J, Baquero F, Spanish Surveillance Group for Respiratory Pathogens. Antimicrob Agents Chemother; 2001 Dec; 45(12):3334-40. PubMed ID: 11709305 [Abstract] [Full Text] [Related]
9. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. Ednie LM, Visalli MA, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 1996 Aug; 40(8):1950-2. PubMed ID: 8843313 [Abstract] [Full Text] [Related]
11. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae. Mazzariol A, Koncan R, Vitali LA, Cornaglia G. J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779 [Abstract] [Full Text] [Related]
12. The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004. Melo-Cristino J, Santos L, Ramirez M, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias. Rev Port Pneumol; 2006 Jun; 12(1):9-30. PubMed ID: 16572254 [Abstract] [Full Text] [Related]
13. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study. Brown SD, Rybak MJ. J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i7-15. PubMed ID: 15265831 [Abstract] [Full Text] [Related]
14. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus. Nord CE, Lindmark A, Persson I. J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369 [No Abstract] [Full Text] [Related]
15. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan. Hsueh PR, Shyr JM, Wu JJ. Clin Microbiol Infect; 2006 Mar; 12(3):296-8. PubMed ID: 16451421 [Abstract] [Full Text] [Related]
16. In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities. Ioannidou S, Tassios PT, Zachariadou L, Salem Z, Kanelopoulou M, Kanavaki S, Chronopoulou G, Petropoulou N, Foustoukou M, Pangalis A, Trikka-Graphakos E, Papafraggas E, Vatopoulos AC. Clin Microbiol Infect; 2003 Jul; 9(7):704-7. PubMed ID: 12925112 [Abstract] [Full Text] [Related]
19. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro. Van Asselt GJ, Sloos JH, Mouton RP, Van Boven CP, Van de Klundert JA. J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004 [Abstract] [Full Text] [Related]